Tetrahydrozoline

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier S9U025Y077, chemically known as 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazole but more generally known as tetrahydrozoline, which bears U.S. National Institutes of Health Compound Identifier 5419. The European Medicines Agency schedules Tetryzoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10955MIG. The term TETRYZOLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). The World Health Organization schedules tetrahydrozoline in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C1CC(C2=CC=CC=C2C1)C3=NCCN3.